AVEO PHARMACEUTICALS INC Business Operations Contracts & Agreements
11 Contracts & Agreements
- Advisory Agreements (3 contracts)
- Collaboration Agreements (4)
- MOUs (1)
- Sales Agreements (2)
- Settlement Agreements (1)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated January 26, 2021, by and between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on May 10, 2021)
- Clinical Trial Collaboration and Supply Agreement, dated January 23, 2021, by and between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on May 10, 2021)
- Stipulation of Settlement, dated January 29, 2018, by and among the Company and the parties named therein (Filed With SEC on May 8, 2018)
- Sales Agreement, dated February 16, 2018, by and between the Company and Leerink Partners LLC (Filed With SEC on February 16, 2018)
- Memorandum of Understanding, dated December 26, 2017, by and among the Company and the parties named therein (Filed With SEC on December 26, 2017)
- Amendment No. 1 to At Market Issuance Sales Agreement (Filed With SEC on May 7, 2015)
- CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on March 11, 2011)
- CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on November 5, 2010)
- FIRST AMENDMENT TO THE AMENDED AND RESTATED COLLABORATION LICENSE AGREEMENT BETWEEN OSI PHARMACEUTICALS, INC. AND AVEO PHARMACEUTICALS, INC. (Filed With SEC on August 6, 2010)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. LICENSE AND RESEARCH COLLABORATION (Filed With SEC on December 16, 2009)
- CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on December 16, 2009)
